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MaBACKGROUND Deﬁbrillation testing is often performed to establish effective arrhythmia termination, but predictors
and consequences of an inadequate deﬁbrillation safety margin (DSM) remain largely unknown.
OBJECTIVES The aims of this study were to develop a simple risk score predictive of an inadequate DSM at implantable
cardioverter-deﬁbrillator (ICD) implantation and to examine the association of an inadequate DSM with adverse events.
METHODS A total of 132,477 ICD Registry implantations between 2010 and 2012 were analyzed. Using logistic regression
models, factors most predictive of an inadequate DSM (deﬁned as the lowest successful energy tested<10 J frommaximal
device output) were identiﬁed, and the association of an inadequate DSM with adverse events was evaluated.
RESULTS Inadequate DSMs occurred in 12,397 patients (9.4%). A simple risk score composed of 8 easily identiﬁable
variables characterized patients at high and low risk for an inadequate DSM, including (with assigned points)
age <70 years (1 point); male sex (1 point); race: black (4 points), Hispanic (2 points), or other (1 point); New York
Heart Association functional class III (1 point) or IV (3 points); no ischemic heart disease (2 points); renal dialysis
(3 points); secondary prevention indication (1 point); and ICD type: single-chamber (2 points) or biventricular
(1 point) device. An inadequate DSM was associated with greater odds of complications (odds ratio: 1.22; 95%
conﬁdence interval: 1.09 to 1.37; p ¼ 0.0006), hospital stay >3 days (odds ratio: 1.24; 95% conﬁdence interval:
1.19 to 1.30; p < 0.0001), and in-hospital mortality (odds ratio: 1.96; 95% conﬁdence interval: 1.63 to 2.36; p < 0.0001).
CONCLUSIONS A simple risk score identiﬁed ICD recipients at risk for an inadequate DSM. An inadequate DSM was
associated with an increased risk for in-hospital adverse events. (J Am Coll Cardiol 2014;64:256–64) © 2014 by the
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257ABB R E V I A T I O N S
AND ACRONYMS
DFT = deﬁbrillation threshold
DSM = deﬁbrillation safety
margin
ICD = implantable
cardioverter-deﬁbrillator
LVEF = left ventricular ejection
fraction
NCDR = National
Cardiovascular Data RegistryD eﬁbrillation testing is often performed atthe time of implantable cardioverter-deﬁbrillator (ICD) implantation by purpose-
fully inducing ventricular ﬁbrillation (VF) to establish
effective arrhythmia detection and termination. In
clinical practice, true deﬁbrillation threshold (DFT)
testing, implying repeated VF induction while decre-
menting shock strength for deﬁbrillation until failure,
is rarely performed. Instead, many operators opt to
demonstrate termination of VF at least once by a
shock energy >10 J below the device’s maximalSEE PAGE 265
NYHA = New York Heart
Association
VF = ventricular ﬁbrillation
programmable output (1). This deﬁbrillation safety
margin (DSM) test speciﬁes the lowest energy tested
that was successful instead of the true DFT, and
often the device is then programmed to at least 10 J
above this value (2). Despite technological advan-
cements, including higher output devices and bipha-
sic waveforms, an inadequate traditional 10-J safety
margin for deﬁbrillation may still occur. When an
inadequate DSM is encountered, further procedural
steps often are required, including changing the char-
acteristics of the discharged energy, repositioning
the right ventricular deﬁbrillation lead, or placing a
subcutaneous system (3). Therefore, a simple risk
score to differentiate ICD recipients at risk for an inad-
equate DSM would aid implanting physicians with
pre-procedural planning and counseling of patients.
Moreover, the presence of an inadequate DSM often
leads to additional further inductions of VF and
repeated deﬁbrillation to test system revisions.
We analyzed data from the ICD Registry of the
National Cardiovascular Data Registry (NCDR), a
national registry of ICD implantations that captures
detailed clinical, patient, and hospital information as
well as in-hospital outcomes. By assessing a large
population of ICD recipients, we sought to examine
variables available pre-procedurally to develop a
simple risk score characterizing patients at risk
for an inadequate DSM during DFT testing. We
also sought to examine the association between an
inadequate DSM and adverse events, including pro-
cedural complications, prolonged hospital stays, and
in-hospital mortality.
METHODS
DATA SOURCE. The NCDR ICD Registry was created in
2006 to meet the requirements of the Centers for
Medicare and Medicaid Services’ coverage with evi-
dence development decision (4). The Heart Rhythm
Society and American College of Cardiology collabo-
rated to establish the national registry, funded byhospital fees and grants from payers and de-
vice companies. Hospitals are mandated
to provide data on Medicare beneﬁciaries
receiving ICDs for the primary prevention of
sudden cardiac death; however, 71.5% of the
1,375 participating hospitals provide data on
all patients undergoing ICD implantation,
and these hospitals submit 88.4% of all ICD
implantations included in the registry (4). This
study included all eligible patients enrolled
after the April 2010 implementation of version
2.0 of the ICD Registry, which included deﬁ-
brillation testing data. ICD Registry data have
undergone quality standard testing, including
an auditing program to conﬁrm completeness and
verify accuracy, as previously detailed (4,5).
STUDY POPULATION. All patients with implantation
data submitted to the registry between April 1, 2010,
and June 30, 2012, were considered for analysis (n ¼
337,547). Patients undergoing generator replacement
or lead revision only procedures (n ¼ 144,665), those
already implanted with a previous ICD or cardiac
resynchronization therapy with deﬁbrillator device
(n ¼ 143), those in whom DFT testing was not per-
formed (n ¼ 59,778), and those with unknown DFT
testing status during the implantation procedure
(n ¼ 484) were excluded from the analysis, leaving
132,477 patients from 1,457 facilities.
DEF IN I T ION OF AN INADEQUATE DSM . Patients
were categorized as having either an adequate or an
inadequate DSM, as deﬁned by the lowest successful
deﬁbrillation energy tested during the ICD implanta-
tion procedure. An inadequate DSM was deﬁned when
the difference between the lowest energy tested that
was successful and the maximal output of the device
implanted was <10 J. Because our goal was to identify
patients in whom a standard right ventricular deﬁ-
brillation lead by itself did not provide adequate
deﬁbrillation, patients with separate high-voltage
leads implanted in the superior vena cava or subcla-
vian position (n ¼ 283) or arrays placed subcutane-
ously (n ¼ 82) also were categorized as having
inadequate DSMs, even if the ﬁnal lowest deﬁbrillating
energy was adequate. ICD recipients with upper limit
of vulnerability testing during the index ICD proce-
dure were not speciﬁcally excluded from the analysis,
provided that DFT testing also was performed.
CANDIDATE VARIABLES. We examined 28 variables
included in registry-captured data that would be
suitable for a risk model as plausibly associated with
an inadequate DSM (Table 1). Variables included pa-
tient demographics, comorbidities, diagnostic data,
and device and lead characteristics.
TABLE 1 Baseline Characteristics
Characteristic
Total
(n ¼ 132,477)
Adequate DSM
(n ¼ 120,080)
Inadequate DSM
(n ¼ 12,397) p Value
Patient demographic characteristics
Age $70 yrs 53,973 (40.7) 49,745 (41.4) 4,228 (34.1) <0.0001
Male 94,677 (71.5) 85,638 (71.3) 9,039 (72.9) 0.0002
Race <0.0001
White 102,869 (77.7) 94,374 (78.6) 8,495 (68.5)
Black 19,294 (14.6) 16,498 (13.7) 2,796 (22.6)
Hispanic 7,331 (5.5) 6,517 (5.4) 814 (6.6)
Other 2,983 (2.3) 2,691 (2.2) 292 (2.4)
Comorbidities
Congestive heart failure 103,147 (77.9) 93,120 (77.5) 10,027 (80.9) <0.0001
NYHA functional class <0.0001
I 19,905 (15.0) 18,246 (15.2) 1,659 (13.4)
II 46,791 (35.3) 42,768 (35.6) 4,023 (32.5)
III 61,817 (46.7) 55,597 (46.3) 6,220 (50.2)
IV 3,451 (2.6) 2,996 (2.5) 455 (3.7)
Nonischemic dilated
cardiomyopathy
46,818 (35.3) 41,548 (34.6) 5,270 (42.5) <0.0001
Syncope 23,063 (17.4) 21,030 (17.5) 2,033 (16.4) 0.0072
Atrial ﬁbrillation/atrial ﬂutter 35,335 (26.7) 32,016 (26.7) 3,319 (26.8) 0.9622
Ventricular tachycardia 41,262 (31.1) 37,359 (31.1) 3,903 (31.5) 0.6342
Cardiac arrest 14,296 (10.8) 12,903 (10.7) 1,393 (11.2) 0.2399
Ischemic heart disease 79,166 (59.8) 72,679 (60.5) 6,487 (52.3) <0.0001
Previous myocardial infarction 65,312 (49.3) 60,096 (50.0) 5,216 (42.1) <0.0001
Previous percutaneous
coronary intervention
43,936 (33.2) 40,447 (33.7) 3,489 (28.1) <0.0001
Previous CABG 39,573 (29.9) 36,454 (30.4) 3,119 (25.2) <0.0001
Primary valvular heart disease 15,257 (11.5) 13,721 (11.4) 1,536 (12.4) 0.0019
Cerebrovascular disease 18,892 (14.3) 17,210 (14.3) 1,682 (13.6) 0.0283
Chronic lung disease 28,336 (21.4) 25,690 (21.4) 2,646 (21.3) 0.4084
Diabetes 50,629 (38.2) 46,080 (38.4) 4,549 (36.7) 0.0010
Sleep apnea 15,929 (12.0) 14,334 (11.9) 1,595 (12.9) 0.0007
Current renal dialysis 3,992 (3.0) 3,375 (2.8) 617 (5.0) <0.0001
Hypertension 104,818 (79.1) 95,117 (79.2) 9,701 (78.3) 0.0364
Patient diagnostic data
Body mass index $30 kg/m2 52,546 (39.7) 47,393 (39.5) 5,153 (41.6) <0.0001
LVEF (%) <0.0001
#30 93,654 (70.7) 84,421 (70.3) 9,233 (74.5)
30 to #40 23,360 (17.6) 21,487 (17.9) 1,873 (15.1)
>40 15,463 (11.7) 14,172 (11.8) 1,291 (10.4)
QRS duration $120 ms 54,248 (40.9) 49,126 (40.9) 5,122 (41.3) 0.3822
Systolic blood pressure
<100 mm Hg
6,676 (5.0) 5,950 (5.0) 726 (5.9) <0.0001
Creatinine level >2.0 mg/dl 9,626 (7.3) 8,465 (7.0) 1,161 (9.4) <0.0001
Device and lead characteristics
ICD indication: primary
prevention
105,507 (79.6) 95,722 (79.7) 9,785 (78.9) 0.0388
ICD type <0.0001
Single chamber 29,111 (22.0) 25,887 (21.6) 3,224 (26.0)
Dual chamber 56,188 (42.4) 51,556 (42.9) 4,632 (37.4)
CRT-D 46,924 (35.4) 42,408 (35.3) 4,516 (36.4)
Single-coil deﬁbrillator lead 23,115 (17.4) 21,077 (17.6) 2,038 (16.4) <0.0001
Values are n (%). Unadjusted pre-procedural characteristics of ICD recipients with and without adequate
DSMs during deﬁbrillation testing are listed.
CABG ¼ coronary artery bypass grafting; CRT-D ¼ cardiac resynchronization therapy with deﬁbrillator; DSM ¼
deﬁbrillator safety margin; ICD ¼ implantable cardioverter-deﬁbrillator; LVEF ¼ left ventricular ejection fraction;
NYHA ¼ New York Heart Association.
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258ADVERSE OUTCOMES. The ﬁrst adverse outcome of
interest was the occurrence of any associated
in-hospital complication during or after ICD implan-
tation. The second outcome was the duration of
hospitalization, from admission to discharge. For
analytical purposes, length of hospital stay was
dichotomized to >3 or #3 days on the basis of
the distribution of the cohort (as a clinically mean-
ingful cutoff and on the basis of a previous ICDRegistry
study [6], as 90% of the cohort had a hospital stay #3
days). The third outcome was the occurrence of
in-hospital mortality during or after ICD implantation.
STATISTICAL ANALYSIS. Unadjusted differences in
baseline characteristics were compared between pa-
tients with adequate versus inadequate DSMs using
chi-square tests for categorical variables. A p
value <0.05 was considered statistically signiﬁcant.
To identify the variables most strongly associated
with an inadequate DSM, the entire cohort was
randomly split into 2 equally sized cohorts. The ﬁrst
cohort was used to develop the models (derivation
cohort, 66,118 patients among 1,426 hospitals),
whereas the second cohort was used to validate the
models (validation cohort, 66,359 patients among
1,405 hospitals). To develop a risk model for predict-
ing an inadequate DSM in those with DFT testing
performed, we performed multivariate logistic
regression with a stepwise selection method (p value
for entry ¼ 0.15, p value for retention ¼ 0.05). Cate-
gorical cut points for continuous variables were
determined both graphically and on the basis
of previous ICD Registry data (6,7). We evaluated
model discrimination and calibration by both
C-statistics and Hosmer-Lemeshow statistics; low
chi-square values and high corresponding p values for
the Hosmer-Lemeshow statistic suggest acceptable
model calibration and ﬁt to the data (8). For the vali-
dation analysis, we investigated model performance
by evaluating predictive ability, overﬁtting indexes,
C-statistics, and Hosmer-Lemeshow statistics. We
excluded multicollinearity by evaluating Pearson
correlation coefﬁcients and variance inﬂation factors.
To identify a simple risk score predictive of an
inadequate DSM, each variable of interest was selected
on the basis of its relative contribution in the logistic
regression model. Of all candidate variables, a larger
model of 16 variables met the retention p value of 0.05.
These variables were ranked by the Wald chi-square
statistic, and variables with the least contribution
were excluded from the model until 8 variables
that captured >90% of the full multivariate model
were left (the ratio of the global chi-square statistic
in the reduced compared with the full model was
TABLE 2 Multivariate Predictors of an Inadequate DSM
Description
Wald Chi-
Square
Beta
Coefﬁcient OR 95% CI Points
Intercept 4,853.4 3.03
Age <70 yrs 42.2 0.19 1.21 1.14–1.28 1
Male 38.9 0.19 1.21 1.14–1.29 1
Black race 234.7 0.53 1.70 1.59–1.82 4
Hispanic 20.5 0.25 1.29 1.15–1.44 2
Other nonwhite race 1.5 0.11 1.11 0.94–1.32 1
NYHA class III 43.0 0.20 1.23 1.15–1.30 1
NYHA class IV 43.5 0.49 1.64 1.41–1.89 3
No ischemic heart disease 75.5 0.25 1.28 1.21–1.35 2
Current renal dialysis 63.3 0.50 1.65 1.46–1.86 3
ICD indication: secondary
prevention
22.1 0.16 1.17 1.10–1.26 1
ICD type: single chamber 55.8 0.26 1.30 1.21–1.39 2
ICD type: CRT-D 18.9 0.15 1.16 1.09–1.25 1
Statistically signiﬁcant predictors associated with an inadequate DSM after
multivariate adjustment in the derivation cohort are listed. Full model C-statistic¼
0.597; Hosmer-Lemeshow goodness-of-ﬁt test: chi-square statistic ¼ 5.56,
p ¼ 0.6969.
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1.
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259evaluated) (9). A point system was derived by assign-
ing a numerical value proportional to the associated
beta coefﬁcient found in multivariate analysis. The
simple arithmetic sum of the point values assigned to
each variable was calculated for all patients, which
then constituted the risk score for an inadequate DSM
during DFT testing. The adequate performance of the
risk score in the validation cohort was conﬁrmed.
Next, we developed hierarchical logistic regression
models to assess the independent association of
an inadequate DSM with each adverse event, by
accounting for clustering of patients within hospitals
in multivariate models (10). Covariates in the multi-
variate models assessing adverse events included
patient demographics (age, sex, and race), comorbid-
ities (congestive heart failure, New York Heart
Association [NYHA] functional class, nonischemic
cardiomyopathy, syncope, atrial ﬁbrillation or atrial
ﬂutter, ventricular tachycardia, cardiac arrest,
ischemic heart disease, previous myocardial infarc-
tion, previous percutaneous coronary intervention,
previous coronary artery bypass graft surgery, primary
valvular heart disease, cerebrovascular disease,
chronic lung disease, diabetes, sleep apnea, current
renal dialysis, and hypertension), diagnostic data
(body mass index, left ventricular ejection fraction
[LVEF], QRS duration, systolic blood pressure, and
creatinine level), and device and lead characteristics
(indication for implantation, device type, single- vs.
dual-coil deﬁbrillator lead). The prevalence of missing
values was <1% for all variables, except LVEF (1.6%),
QRS duration (6.6%), and single- versus dual-coil
deﬁbrillation lead (12.0%). For categorical variables
with yes-or-no responses, missing data were assumed
to represent no responses. For variables with >1%
missing data, the median value for the entire cohort
was imputed, and a dummy variable indicating
whether the variable was missing was created. As a
secondary analysis, we repeated the model analyses
using the multiple imputation method to handle
missing values, which produced no meaningful
changes of the results. Multiple imputations were
performed on the basis of the EM algorithm, as previ-
ously described (11). Statistical tests were 2 sided and
considered signiﬁcant if they yielded p values <0.05.
Analyses were performed using SAS Statistical Pack-
age version 9.2 (SAS Institute, Cary, North Carolina).
RESULTS
Of 132,477 total ICD recipients with deﬁbrillation
testing performed, inadequate DSMs occurred in
12,397 patients (9.4%). Baseline characteristics of thestudy population as a whole and the unadjusted
association of each characteristic with an adequate
versus an inadequate DSM are presented in Table 1. In
unadjusted analysis, variables associated with an
inadequate DSM included younger age, male sex,
nonwhite race, congestive heart failure, worsened
NYHA heart failure class, nonischemic cardiomyo-
pathy, primary valvular heart disease, sleep apnea,
current renal dialysis, higher body mass index,
lower LVEF, lower systolic blood pressure, higher
creatinine level, secondary prevention indication,
single-chamber or cardiac resynchronization therapy
deﬁbrillator implantation, and single-coil deﬁbrillator
lead implantation. Inadequate DSMs occurred less
often in ICD recipients with histories of syncope,
ischemic heart disease, previous myocardial infarc-
tion, previous percutaneous coronary intervention,
previous coronary artery bypass graft surgery, cere-
brovascular disease, and diabetes. In general, ICD
recipients with known status of deﬁbrillation testing
included in the study differed from ICD recipients
who required exclusion because of unknown status of
deﬁbrillation testing with respect to several pre-
procedural characteristics (Online Table 1).
RISK SCORE FOR AN INADEQUATE DSM. For the
derivation cohort, the multivariate stepwise logistic
regression for the outcome of an inadequate DSM
resulted in a larger model composed of 16 variables,
with a C-statistic of 0.603 and a Hosmer-Lemeshow
goodness-of-ﬁt chi-square statistic of 5.68 (p ¼
0.6832). The simple risk score was constructed from 8
CENTRAL ILLUST
Implantable Cardiov
In addition to display
the proportion of pa
scores is shown.
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260variables, which accounted for >90% of the explained
variance (Table 2). The multivariate model from the
same derivation cohort limited to these 8 variables
resulted in a C-statistic of 0.597 and a Hosmer-
Lemeshow goodness-of-ﬁt chi-square statistic of 5.56
(p ¼ 0.6969). In the validation cohort, the same
8-variable multivariate model resulted in a C-statistic
of 0.597 and a Hosmer-Lemeshow goodness-of-ﬁt chi-
square statistic of 8.49 (p ¼ 0.3874). P values >0.05 in
all models suggested reasonable calibration, with
acceptable model ﬁt to the data. An additional
approach for model validation was undertaken to
conﬁrm that the predicted prevalence of an inadequate
DSM was indeed associated with a higher observed
prevalence of an inadequate DSM in the validation
cohort (Online Fig. 1).RATION Predictors and Risk Score of an Inadequate DSM at
erter-Deﬁbrillation Implantation
ing the point system delineation for the risk score used in this study,
tients with inadequate deﬁbrillation safety margins (DSMs) across riskThe risk for an inadequate DSM increased from
4.9% in ICD recipients with scores of 0 (0.8% of
the total cohort) to 24.5% in ICD recipients with
scores $12 (0.5% of the total cohort). Among ICD
recipients with risk scores #3 (39.6% of the entire
cohort), 6.8% experienced inadequate DSMs. In
contrast, among ICD recipients with risk scores $7
(18.0% of the entire cohort), 14.9% experienced
inadequate DSMs. The distribution of the risk score
and the percent of patients with inadequate DSMs
among different risk score groups in both the deri-
vation and validation cohorts are shown in the Central
Illustration and Figure 1.
ASSOCIATION OF AN INADEQUATE DSM WITH
PROCEDURE COMPLICATIONS. As shown in Table 3,
the crude risk for any associated procedural compli-
cation was higher in those with inadequate DSMs
(2.69%) than in those with adequate DSMs (2.33%).
Both unadjusted and multivariate-adjusted analyses
of the association between an inadequate DSM and
complications are shown in Figure 2. After adjustment
for potential confounders, those with inadequate
DSMs had signiﬁcantly greater odds of any associated
procedural complication (odds ratio: 1.22; 95% conﬁ-
dence interval: 1.09 to 1.37; p ¼ 0.0006).
ASSOCIATION OF AN INADEQUATE DSM WITH
LENGTH OF HOSPITAL STAY. The mean length of
hospital stay for the entire cohort was 1.65  3.82
days. The mean length of stay was signiﬁcantly longer
in ICD recipients with inadequate DSMs than in those
with adequate DSMs (1.93  4.60 vs. 1.62  3.73, p <
0.0001), as seen in Table 3. Both unadjusted and
multivariate-adjusted analyses of the association
between an inadequate DSM and length of hospital
stay are shown in Figure 2. After adjustment for
potential confounders, ICD recipients with inade-
quate DSMs had greater odds of a hospital stay >3
days compared with those with adequate DSMs (odds
ratio: 1.24; 95% conﬁdence interval: 1.19 to 1.30;
p < 0.0001).
ASSOCIATION OF AN INADEQUATE DSM WITH IN-
HOSPITAL MORTALITY. The crude risk for in-
hospital mortality was signiﬁcantly higher in those
with inadequate DSMs (0.40%) compared with those
with adequate DSMs (0.20%) (Table 3). Both unad-
justed and multivariate-adjusted analyses of the as-
sociation between an inadequate DSM and in-hospital
mortality are shown in Figure 2. After adjustment for
potential confounders, ICD recipients with inadequate
DSMs experienced greater odds of in-hospital mortal-
ity compared with those with adequate DSMs (odds
ratio: 1.96; 95% conﬁdence interval: 1.63 to 2.36;
p < 0.0001).
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FIGURE 1 Distribution of Risk Scores
The distributions of risk scores for an inadequate deﬁbrillation safety margin (DSM) are
shown for both the derivation and validation cohorts.
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261DISCUSSION
In a large, nationally representative sample of 132,477
ICD recipients undergoing DFT testing over a 2-year
period, approximately 1 in 10 patients (9.4%) failed
to have adequate DSMs despite the implantation
of modern devices. We identiﬁed several patient
characteristics that predicted an inadequate DSM
and developed a simple risk score using 8 pre-
procedural variables to help distinguish those ICD
recipients at higher and lower risk. After multivariate
adjustment for potential confounders, an inadequate
DSM discovered during DFT testing was associated
with more than 20% greater odds of other procedural
complications and prolonged hospital stay (>3 days)
and almost 2-fold greater odds of in-hospitalmortality.
Previous studies examining the incidence and pre-
dictors of an inadequate DSM were smaller, did not
include modern devices with higher maximal output
(35 to 41 J), andwere not powered to detect differences
in complications and other adverse events during and
immediately after device implantation (12–15). The
prevalence of a highDFT or an inadequate DSM in these
previous studies ranged from 3.9% to 11%. Altogether,
variables predictive of a high DFT or an inadequate
DSM in these studies included worsened NYHA class,
low LVEF, no history of bypass surgery, no history of
myocardial infarction, prior amiodarone use, VF as the
presenting rhythm, QRS duration $200 ms, larger left
ventricular end-diastolic dimension, and prolonged
procedure time. Two of these previous studies eval-
uated subsequent outcomes in those with abnormal
deﬁbrillation testing parameters. Shukla et al. (12)
found that a high DFT did not affect 6-month sur-
vival in the cohort, while Mainigi et al. (13) found
that an elevated DFT itself was not associated with
worsened 2-year mortality. In the present study,
despite the use of more modern devices with higher
maximal energy output, a 9.4% prevalence of an
inadequate DSM was similar to previously reported
studies, potentially suggesting the implantation of a
sicker heart failure patient population with contem-
porary ICDs. Unfortunately, the ICD Registry used in
the present study does not contain comprehensive
echocardiographic and pre-procedural medication
data, and therefore left ventricular dimension and
amiodarone use could not be analyzed in our multi-
variate models. However, with more than 12,000
events that met the criteria for an inadequate DSM,
our study provided ample power to identify a simple
risk score that could be used by clinicians to more
accurately assess the risk for an inadequate DSM.
By distinguishing ICD recipients with lower risk
(score #3) and higher risk (score $7) for aninadequate DSM with variables available before the
procedure, the simple risk score may aid operators in
preparing for ICD procedures on the basis of the
estimated risk for an inadequate DSM occurring
during the procedure. It is particularly important to
identify ICD recipients with high risk for an inade-
quate DSM, given the greater likelihood that a
change in clinical management may be required.
Also, armed with information from the simple risk
score, operators may be better able to counsel
patients regarding the probability of requiring addi-
tional steps to the procedure, including the need for
additional hardware and/or testing. Operators also
may be better prepared and be able to alter their
approaches (such as repositioning or ensuring that
the device implanted has programmable energy
characteristics that can be altered) in those ICD re-
cipients most vulnerable. It should be noted that ICD
recipients with lower risk scores (#3) still had a
measurable 4.8% to 6.8% prevalence of an inade-
quate DSM during DFT testing, suggesting that the
risk score proposed in the present study was still
unable to perfectly predict those ICD recipients who
were not at risk for an inadequate DSM.
Although our study was not equipped to identify
the underlying mechanisms responsible for associa-
tions between predictors that constituted the simple
risk score and an inadequate DSM and should there-
fore be considered hypothesis generating, several
plausible explanations could be entertained. The
TABLE 3 Adverse Ev
Adverse Event
Any complication
Length of stay (implan
discharge), days
In-hospital mortality
Speciﬁc associated com
Cardiac arrest
Cardiac perforation
Set screw problem
Lead dislodgement
Pneumothorax
Hematoma
Coronary venous dis
Device-related infect
Pericardial tamponad
Transient ischemic at
or stroke
Drug reaction
Venous obstruction
Conduction block
Hemothorax
Myocardial infarction
Urgent cardiac surge
Peripheral embolus
Peripheral nerve inju
Cardiac valve injury
Values are n (%) or mean 
stratiﬁed by an adequate v
Abbreviations as in Tabl
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262associations of age <70 years and male sex with an
inadequate DSM may be related to more muscle
or tissue mass, not fully captured by the body
mass index measurement, blunting the effect of
deﬁbrillation energy delivered and increasing the
chance of an inadequate DSM. Those of nonwhite race
had increased risk for an inadequate DSM, which was
most prominent in blacks. It is plausible that un-
measured factors may explain this association,
including those related to disparities in health care
experienced by nonwhite races or the existence of left
ventricular hypertrophy (16). An association between
worsened NYHA heart failure class and an inadequate
DSM has previously been described (15) and may be
related to enlarged cardiac chambers or overall end-
stage disease that results in an inability to terminate
VF even with high-energy shocks. Similarly, a lack of
ischemic heart disease may indicate a susceptibility
to difﬁcult arrhythmia termination in those with
nonischemic cardiomyopathy. Patients currently on
renal dialysis may be at risk for an inadequate DSM
for a multitude of reasons, including left ventricular
hypertrophy (17) or electrolyte abnormalities thatents Stratiﬁed by Deﬁbrillation Safety Margin Status
Total
(n ¼ 132,477)
Adequate DSM
(n ¼ 120,080)
Inadequate DSM
(n ¼ 12,397) p Value
3,136 (2.26) 2,802 (2.33) 334 (2.69) 0.0119
t to 1.65  3.82 1.62  3.73 1.93  4.60 <0.0001
292 (0.22) 242 (0.20) 50 (0.40) <0.0001
plication
217 (0.16) 170 (0.14) 47 (0.38) 0.0000
71 (0.05) 59 (0.05) 12 (0.10) 0.0290
39 (0.03) 31 (0.03) 8 (0.06) 0.0167
1,241 (0.94) 1,120 (0.93) 121 (0.98) 0.6335
430 (0.32) 391 (0.33) 39 (0.31) 0.8372
417 (0.31) 368 (0.31) 49 (0.40) 0.0929
section 146 (0.11) 130 (0.11) 16 (0.13) 0.5063
ion 108 (0.08) 95 (0.08) 13 (0.10) 0.3389
e 72 (0.05) 62 (0.05) 10 (0.08) 0.1867
tack 66 (0.05) 57 (0.05) 9 (0.07) 0.2326
55 (0.04) 49 (0.04) 6 (0.05) 0.6928
41 (0.03) 35 (0.03) 6 (0.05) 0.2460
40 (0.03) 34 (0.03) 6 (0.05) 0.2204
31 (0.02) 28 (0.02) 3 (0.02) 0.9513
27 (0.02) 24 (0.02) 3 (0.02) 0.7544
ry 20 (0.02) 19 (0.02) 1 (0.01) 0.5034
17 (0.01) 16 (0.01) 1 (0.01) 0.6227
ry 2 (0.00) 2 (0.00) 0 (0.00) 0.6495
1 (0.00) 1 (0.00) 0 (0.00) 0.7480
SD. Prevalence of adverse events and speciﬁc complications from ICD implantation
ersus an inadequate DSM are listed.
e 1.may alter cardiac electrical properties (18). A sec-
ondary prevention indication for ICD implantation
may act as a marker for patients at risk for intractable
malignant arrhythmias, a worsened comorbid state,
or amiodarone use. The addition of an atrial lead that
comprises a dual-chamber ICD device would not be
expected to inherently improve the DFT. Therefore,
the underlying mechanism of a protective association
from dual-chamber ICD implantation remains uncer-
tain and will need to be examined more thoroughly.
An inadequate DSM may lead to additional DFT
testing that itself can be associated with complications
related to shocks or induced VF with concomitant
hypoperfusion, potentially leading to signiﬁcant
morbidity and mortality. Refractory VF with failed
multiple deﬁbrillations can occur, and pulseless elec-
trical activity has been reported after termination of VF
(19). Signiﬁcantly greater odds of adverse events in
those with inadequate DSMs were consistent across all
3 outcomes studied and persisted despite adjustment
for potential confounders. These increased risks have
important ramiﬁcations relevant to patients and
practicing physicians, particularly because these
eventswill likely adversely affect patient quality of life
and translate into increased health care utilization and
costs. Although it is possible that an increasedDSMand
the additional deﬁbrillations that invariably resulted
from the subsequent further DFT testing directly
resulted in an increased risk for all 3 adverse outcomes,
alternative explanations should be entertained. For
example, it is possible that residual confounding by
unmeasured factors explains part or all of the associ-
ation between an inadequate DSM and adverse events.
In general, our simple risk score identiﬁed may be
useful to operators when counseling patients regard-
ing the overall risks versus beneﬁts of ICD implanta-
tion. However, this cross-sectional study evaluating
in-hospital outcomes underscores the need for long-
term outcome data regarding ICD recipients who do
and do not undergo DFT testing, in addition to speciﬁc
data regarding long-term outcomes in those with in-
adequate DSMs. It is possible that data from the SIM-
PLE (Shockless Implant Evaluation) trial comparing
outcomes in ICD recipients randomized to DFT versus
no DFT testing may provide further insights (20).
STUDY LIMITATIONS. First, because of limitations of
the data collected in the ICD Registry, we were not able
to assess the impact of several covariates previously
associated with a high DFT during ICD implantation,
including echocardiographic parameters such as left
ventricular mass or size, admission medications such
as amiodarone, and speciﬁc procedural characteristics
such as total procedural time (12,14,21). Omission of
Adverse Outcome
Any Associated Procedural Complication
Length of Hospital Stay > 3 Days
In-Hospital Mortality
Odds Ratio of Outcome in Patients with an
Inadequate Defibrillation Safety Margin OR (95% CI) P value
1.30 ( 1.16 - 1.45 )
1.22 ( 1.09 - 1.37 )
1.29 ( 1.24 - 1.35 )
1.24 ( 1.19 - 1.30 )
2.20 ( 1.80 - 2.69 )
1.96 ( 1.63 - 2.36 )
<0.0001
0.0006
<0.0001
<0.0001
<0.0001
<0.0001
<<<Adverse Event Less Likely
0.5 1 2 4
Adverse Event More Likely>>>
Unadjusted Odds Ratio Multivariable Adjusted Odds Ratio*
FIGURE 2 Inadequate DSM During ICD Implantation and Adverse Events in ICD Recipients
Unadjusted (salmon boxes) and multivariate-adjusted (red boxes) odds ratios (ORs) of any associated procedural complication, length of hospital stay >3 days, and
in-hospital mortality among implantable cardioverter-deﬁbrillator (ICD) recipients with inadequate deﬁbrillation safety margins (DSMs) during deﬁbrillation testing. The
reference group for each analysis is ICD recipients with adequate DSM. The horizontal error bars denote 95% conﬁdence intervals (CIs). *Adjusted for patient
demographics (age, sex, and race), comorbidities (congestive heart failure, New York Heart Association functional class, nonischemic cardiomyopathy, syncope, atrial
ﬁbrillation or atrial ﬂutter, ventricular tachycardia, cardiac arrest, ischemic heart disease, previous myocardial infarction, previous percutaneous coronary intervention,
previous coronary artery bypass graft surgery, primary valvular heart disease, cerebrovascular disease, chronic lung disease, diabetes, sleep apnea, current renal dialysis,
and hypertension), diagnostic data (body mass index, left ventricular ejection fraction, QRS duration, systolic blood pressure, and creatinine level), and device and lead
characteristics (indication for implantation, device type, single- vs. dual-coil deﬁbrillator lead).
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263these covariatesmay reduce the utility of the risk score
identiﬁed in our study, although we were still able to
identify 8 variables that differentiated ICD recipients
at risk for an inadequate DSM.
Second, although we performed internal validation
by using both derivation and validation cohorts from
the total ICD Registry population, we did not perform
external validation in a different population. There-
fore, the risk score may not be generalizable to other
ICD populations, such as those in different countries
or who did not undergo DFT testing.
Third, the simple risk score did not have ideal
discriminative ability in predicting those with
adequate versus inadequate DSMs, and we cannot
rule out the possibility that unmeasured variables
may have provided better discrimination. However,
this is the ﬁrst described risk model that relied on a
simply calculated score to aid clinicians in classifying
the risk for an inadequate DSM in ICD recipients.
Finally, as with any observational study, we cannot
exclude the possibility that residual confounding ex-
plains the associations found between an inadequate
DSM and other procedural complications, prolonged
hospital stays, and in-hospital mortality despite
our extensive attempts at multivariate adjustment.
For example, although multiple comorbidities were
controlled for, because of the possibility ofunmeasured confounders, a high DFT and an inade-
quate DSM may have been markers for ICD recipients
who were more ill and, therefore, more likely to
experience adverse events.
CONCLUSIONS
In a large, national registry of ﬁrst-time ICD recipients,
speciﬁc patient characteristics predicted an inade-
quate DSM during DFT testing that was captured by a
simple risk score to differentiate those at higher and
lower risk. An inadequate DSM at the time of ICD im-
plantation was associated with subsequent adverse
events, including procedural complications, pro-
longed hospital stays, and in-hospital mortality. This
simple risk score may identify ICD recipients in whom
DFT testing is most likely to change clinical manage-
ment, therefore distinguishing those who most war-
rant this testing. Future studies are necessary to
evaluate the mechanisms underlying the association
between an inadequate DSM and adverse events and
whether DFT testing itself is responsible for the
adverse outcomes observed.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE 1: Nearly
1 in 10 patients have inadequate DSMs during the im-
plantation of ICDs, and this is associated with a higher risk
for complications, prolonged hospital stay, and in-
hospital mortality.
COMPETENCY IN MEDICAL KNOWLEDGE 2: The
following risk factors are associated with an inadequate
DSM: age <70 years (1 point); male sex (1 point); black
race (4 points), Hispanic ethnicity (2 points), or other
non-Caucasian ethnicity (1 point); NYHA functional class
III (1 point) or IV (3 points) heart failure; absence of
ischemic heart disease (2 points); end-stage renal disease
requiring dialysis (3 points); secondary prevention indi-
cation (1 point); and single-chamber (2 points) or biven-
tricular (1 point) ICD type.
COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS: Physicians implanting ICDs
should know the risk factors associated with an inade-
quate DSM.
COMPETENCY IN INTERPERSONAL AND
COMMUNICATION SKILLS: Physicians should counsel
patients at risk for an inadequate DSM regarding the
greater chance that they may require additional testing
during the implantation procedure to ensure an adequate
margin of safety.
TRANSLATIONAL OUTLOOK 1: Future studies should
investigate the mechanisms underlying the association
between risk factors and deﬁbrillation threshold.
TRANSLATIONAL OUTLOOK 2: Long-term studies
are needed to assess the clinical outcomes of patients
with inadequate DSMs after ICD implantation.
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